Robert H. Underwood is a partner in the law firm of McDermott Will & Emery LLP and is based in the Firm’s Boston office. Bob has extensive experience creating and evaluating intellectual property protection in the areas of life sciences and chemistry including antibody-based and other protein therapeutics, nucleic acid and genetic technology, small molecule therapeutics, medicinal chemistry, drug discovery and development, organic chemistry, polymers, catalysts, and drug formulation and delivery. His practice focuses on patent portfolio development and management, patent prosecution, opinions, licensing, due diligence and related counseling. He also assists clients with product planning matters as they relate to intellectual property, patent life-cycle management and the acquisition and divestment of intellectual property assets.
Articles in the National Law Review database by Robert H. Underwood, Ph.D.